Elevation Wealth Partners’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$114K Buy
315
+39
+14% +$13.3K 0.03% 180
2026
Q1
$97.1K Sell
276
-26
-9% -$9.27K 0.03% 170
2025
Q4
$98.8K Buy
302
+40
+15% +$12.7K 0.04% 171
2025
Q3
$73.9K Buy
262
+30
+13% +$8.7K 0.03% 201
2025
Q2
$64.8K Hold
232
0.03% 208
2025
Q1
$72.3K Hold
232
0.03% 195
2024
Q4
$60.5K Buy
232
+26
+13% +$7.71K 0.03% 209
2024
Q3
$66.4K Hold
206
0.03% 196
2024
Q2
$64.4K Hold
206
0.03% 194
2024
Q1
$58.6K Hold
206
0.03% 204
2023
Q4
$55.4K Hold
206
0.03% 197
2023
Q3
$55.4K Hold
206
0.05% 140
2023
Q2
$45.7K Hold
206
0.04% 162
2023
Q1
$49.8K Buy
+206
New +$50.6K 0.05% 155

Other funds holding AMGN

Elevation Wealth Partners's AMGN Position: Q2 2026 in Review

Elevation Wealth Partners increased its Amgen (AMGN) stake by 14% in Q2 2026, buying an estimated $13.3K and bringing the position to 315 shares worth $114K. The position accounts for 0.03% of the portfolio, ranked #180.

Elevation Wealth Partners first reported a position in AMGN in Q1 2023 and has held it in 14 quarters since. 1,264 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Elevation Wealth Partners held 315 shares of Amgen worth $114K as of Q2 2026.
  • Elevation Wealth Partners bought 39 Amgen shares in Q2 2026, an estimated $13.3K.
  • Amgen made up 0.03% of Elevation Wealth Partners's portfolio in Q2 2026, its #180 holding.
  • Elevation Wealth Partners first reported a position in Amgen in Q1 2023 and has held it in 14 quarters since.
  • 1,264 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Elevation Wealth Partners's 13F filing for Q2 2026, filed 8 Jul 2026.